How has artificial intelligence impacted COVID-19 drug repurposing and what lessons have we learned?

E. Sila Ozdemir, Srivathsan V. Ranganathan, Ruth Nussinov*

*Corresponding author for this work

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)1061-1065
Number of pages5
JournalExpert Opinion on Drug Discovery
Issue number10
StatePublished - 2022


  • COVID-19
  • Drug repurposing
  • artificial intelligence
  • computational biology
  • knowledge graph
  • machine learning
  • personalized treatment
  • precision medicine

Cite this